Cantor Fitzgerald keeps USD 209.00 target for Molina Healthcare stock
Published on 10/15/2026 at 19:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCantor Fitzgerald keeps its view
- Cantor Fitzgerald maintained a USD 209.00 target and Neutral rating on October 9, 2026.
- Molina Healthcare is expected to report third-quarter revenue of USD 10.85 billion on October 21, 2026.
- Molina Healthcare stock costs EUR 189.88 at Lang & Schwarz on October 15, 2026 at 7:30 p.m. CEST, up 1.66 percent on Nasdaq versus the prior close of October 14, 2026.
- The stock's 52-week range runs from USD 121.06 to USD 244.89.
Molina Healthcare (ISIN US60855R1005) remains anchored to a USD 209.00 target from Cantor Fitzgerald, which reiterated a Neutral rating on October 9, 2026, according to Investing.com. Against the Nasdaq price of USD 212.67 at 1:31 p.m. ET on October 15, 2026, that target is 1.73 percent below the price. Molina Healthcare stock was trading at EUR 189.88 at Lang & Schwarz on October 15, 2026 at 7:30 p.m. CEST, up 1.66 percent on Nasdaq versus the prior close of October 14, 2026.
Results arrive October 21
The next scheduled test is close. MarketBeat reported on October 14, 2026 that Molina Healthcare is expected to release third-quarter results after the market closes on October 21, 2026. Analysts cited by the outlet expect revenue of USD 10.85 billion and earnings per share of USD 0.79, with the conference call scheduled for October 22, 2026 at 8:00 a.m. ET.
Price remains below yearly high
The Nasdaq quotation of USD 212.67 on October 15, 2026 sits 13.16 percent below the 52-week high of USD 244.89 and well above the 52-week low of USD 121.06. The same-day volume was 316,370 shares against an average of 900,829 shares. The euro quotation therefore frames the stock at a higher level than its October 2026 low, while the target and the upcoming results provide the more immediate reference points.
Valuation and peer comparison
Molina Healthcare had a market capitalization of USD 11.1 billion on October 15, 2026. The consensus picture collected by MarketBeat covered 17 analysts and showed a Hold rating with an average target of USD 202.44.
Comparison with peers
Molina Healthcare: plus 1.66 percent, market capitalization USD 11.1 billion
Centene (NYSE, USD): plus 0.41 percent, P/E minus 6.74, market capitalization USD 34.8 billion
Elevance Health (NYSE, USD): plus 0.01 percent, P/E 19.05, market capitalization USD 92.9 billion
Trading perspective in euros
The stock's current euro quotation sits below the Cantor Fitzgerald target when measured against the Nasdaq listing, while the next scheduled report arrives within six days. The price movement is presented as a market reading rather than a forecast.
The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.
Molina Healthcare market data
- Company: Molina Healthcare, Inc.
- ISIN: US60855R1005
- Ticker: MOH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 7:30 p.m. CEST): EUR 189.88
- Daily change on Nasdaq: plus 1.66 percent versus the prior close of October 14, 2026
- Market capitalization: USD 11.1 billion (as of October 15, 2026)
- 52-week range: USD 121.06-244.89 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
